Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | PSMB5 | P28074 | 12/20 | 0.41 |
| ▸ | PSMB8 | P28062 | 4/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | PSMB9 | P28065 | 3/20 | 0.39 |
| ▸ | CA1 | P00915 | 4/20 | 0.38 |
| ▸ | CA2 | P00918 | 4/20 | 0.38 |
| ▸ | PSMB1 | P20618 | 2/20 | 0.37 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25399173 | 1.00 | NPSR1 (0.42) | NPSR1PSMB5PSMB8POLBCYP1A2 | |
| SCHEMBL25401468 | 0.85 | NPSR1 (0.50) | NPSR1PSMB5PSMB8POLBCYP1A2 | |
| SCHEMBL25401463 | 0.85 | NPSR1 (0.50) | NPSR1PSMB5PSMB8POLBCYP1A2 | |
| SCHEMBL25399374 | 0.84 | POLB (0.39) | NPSR1PSMB5PSMB8POLBCYP1A2 | |
| SCHEMBL25399372 | 0.84 | POLB (0.39) | NPSR1PSMB5PSMB8POLBCYP1A2 | |
| SCHEMBL25400492 | 0.83 | NPSR1 (0.43) | NPSR1PSMB5PSMB8POLBCYP1A2 | |
| SCHEMBL29846653 | 0.83 | NPSR1 (0.43) | NPSR1PSMB5PSMB8POLBCYP1A2 | |
| SCHEMBL25400488 | 0.83 | NPSR1 (0.43) | NPSR1PSMB5PSMB8POLBCYP1A2 | |
| SCHEMBL29846176 | 0.82 | CA1 (0.46) | NPSR1PSMB5PSMB8POLBCYP1A2 | |
| SCHEMBL25397422 | 0.82 | PSMB5 (0.52) | NPSR1PSMB5PSMB8POLBCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12570675-B2 | Boronic acid compounds | LG CHEM, LTD. (KR) | 2026-03-10 | — | — | US | disclosed |
| US-20240101579-A1 | BORONIC ACID COMPOUNDS | LG CHEM, LTD. (KR) | 2024-03-28 | — | — | US | disclosed |
| EP-4242213-A1 | BORONIC ACID COMPOUND | Lg Chem, Ltd. (KR) | 2023-09-13 | — | — | EP | disclosed |
| WO-2022123530-A1 | BORONIC ACID COMPOUND | 주식회사 엘지화학 | 2022-06-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570675-B2 | Boronic acid compounds | PSMB6, PSMB3, PSMB2 | NPSR1 2598/4885PSMB5 10/4885PSMB8 5/4885 |
| US-20240101579-A1 | BORONIC ACID COMPOUNDS | PSMB11, PSMB1, BACH1 | NPSR1 4263/4885PSMB5 7/4885PSMB8 28/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.